Oncology
 |
|
9 december 2019 07:03:08 |
| Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours (British Journal of Cancer) |
|
Tweet |
| 247 viewsCategory: Oncology |
 Blue light-triggered optogenetic system for treating uveal melanoma (Oncogene)Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
